Harrow Jobs & Careers

Ledgewood NJ

Founded: 1998
Employees: 175
Total Funding: $283.7M

Founded by Mark Baum in 1998.

About Harrow

Harrow’s ophthalmic pharmaceutical portfolio is one of the most comprehensive in the industry, including: An expanding Retina Portfolio including IHEEZO ® , TRIESENCE ® , BYOOVIZ TM , and OPUVIZ TM A broad Dry Eye Disease product line , led by VEVYE ® and bolstered by well-known adjacent ocular surface disease products such as FLAREX ® and FRESHKOTE ® A peri-operative Surgical product line , led by TRIESENCE ® , and BYQLOVI TM A Rare and Specialty product line , which includes various high-need and utility products such as ILEVRO ® , NATACYN ® , and VERKAZIA ® A robust internal development pipeline with multiple late-stage candidates, including MELT-300, MELT-210, H-N08, and CR-01 The...